Building A DNA Delivery System With Poseida Tx CEO Eric Ostertag, M.D., Ph.D.
Source: Bioprocess Online
![20_12_BPO_BusBiotech_Social_ep64 20_12_BPO_BusBiotech_Social_ep64](https://vertassets.blob.core.windows.net/image/983988f7/983988f7-f19d-435a-a9a2-3fca8ad7fe7d/375_250-20_12_bpo_busbiotech_social_ep64.png)
Eric Ostertag, M.D., Ph.D., wanted to launch a biotech. When University of Pennsylvania department heads said no to a licensing deal for lack of a CEO, Dr. Ostertag convinced them he could run the company. Many bold moves later, Dr. Ostertag is founder and CEO at Poseida Therapeutics, a company that's doing things never seen before in the field of CAR T-cell and gene therapies for multiple myeloma and prostate cancer. On this week's episode of The Business of Biotech, Dr. Ostertag gives us a tour of the architecture supporting Poseida's unique 3-tiered development and manufacturing platform.
access the Podcast!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
Bioprocess Online
This website uses cookies to ensure you get the best experience on our website. Learn more